Clinical Trial Update: Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sulfasalazine to prevent acute diarrhea in cancer patients undergoing pelvic radiation therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Diarrhea

Drugs mentioned

• Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Diarrhea, Gastrointestinal Complications | Phase 3 | Status: COMPLETED | Results posted: 2017-04-04